Literature DB >> 18370188

Mechanism by which electroporation mediates DNA migration and entry into cells and targeted tissues.

Marie-Pierre Rols1.   

Abstract

Cell membranes can be transiently permeabilized under application of electric pulses that allow hydrophilic therapeutic molecules, such as anticancer drugs and DNA, to enter into cells and tissues. This process, called electropermeabilization or electroporation, has been rapidly developed over the last decade to deliver genes to tissues and organs, but there is a general agreement that very little is known about what is really occurring during membrane electropermeabilization. It is well accepted that the entry of small molecules, such as anticancer drugs, occurs through simple diffusion while the entry of macromolecules, such as DNA, occurs through a multistep mechanism involving the electrophoretically driven association of the DNA molecule with the destabilized membrane and then its passage across the membrane. Therefore, successful DNA electrotransfer into cells depends not only on cell permeabilization but also on the way plasmid DNA interacts with the plasma membrane and, once into the cell, migrates toward the nuclei.

Mesh:

Substances:

Year:  2008        PMID: 18370188     DOI: 10.1007/978-1-59745-194-9_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  Nucleofection disrupts tight junction fence function to alter membrane polarity of renal epithelial cells.

Authors:  Di Mo; Beth A Potter; Carol A Bertrand; Jeffrey D Hildebrand; Jennifer R Bruns; Ora A Weisz
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-11

Review 2.  Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments.

Authors:  Angela M Bodles-Brakhop; Richard Heller; Ruxandra Draghia-Akli
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

Review 3.  Delivery technologies for genome editing.

Authors:  Hao Yin; Kevin J Kauffman; Daniel G Anderson
Journal:  Nat Rev Drug Discov       Date:  2017-03-24       Impact factor: 84.694

4.  Direct Current Helium Plasma for In vivo Delivery of Plasmid DNA Encoding Erythropoietin to Murine Skin.

Authors:  Mark J Jaroszeski; Taryn Harvey-Chapman; Andrew Hoff; Reginald Atkins; Richard J Connolly
Journal:  Plasma Med       Date:  2017

5.  DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells.

Authors:  Daejin Kim; Chien-Fu Hung; T-C Wu; Yeong-Min Park
Journal:  Vaccine       Date:  2010-09-17       Impact factor: 3.641

Review 6.  Microscale electroporation: challenges and perspectives for clinical applications.

Authors:  Won Gu Lee; Utkan Demirci; Ali Khademhosseini
Journal:  Integr Biol (Camb)       Date:  2009-01-29       Impact factor: 2.192

7.  Transfection of mouse cochlear explants by electroporation.

Authors:  Elizabeth C Driver; Matthew W Kelley
Journal:  Curr Protoc Neurosci       Date:  2010-04

8.  Electroporation to deliver plasmid DNA into rat dental tissues.

Authors:  Shaomian Yao; Dina L Gutierrez; Sherry Ring; Dawen Liu; Gary E Wise
Journal:  J Gene Med       Date:  2010-12       Impact factor: 4.565

9.  Electroporation optimization to deliver plasmid DNA into dental follicle cells.

Authors:  Shaomian Yao; Samir Rana; Dawen Liu; Gary E Wise
Journal:  Biotechnol J       Date:  2009-10       Impact factor: 4.677

10.  Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.

Authors:  T H Kang; J-Y Chung; A Monie; S I Pai; C-F Hung; T-C Wu
Journal:  Gene Ther       Date:  2009-11-26       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.